Time to overcome pretreatment HIV drug resistance

Affiliations

¹ Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland. Electronic address: sabine.yerly@hcuge.ch.
² Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland.

Free article

Comment

Sabine Yerly et al. Lancet Infect Dis. 2018 Mar.

Free article

. 2018 Mar;18(3):239-240.

doi: 10.1016/S1473-3099(17)30709-0. Epub 2017 Nov 30.

¹ Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland. Electronic address: sabine.yerly@hcuge.ch.
² Laboratory of Virology, AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva 1211, Switzerland.

No abstract available

Comment on

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade Forero L, Kaleebu P, Watera C, Aghokeng A, Mutenda N, Dzangare J, Hone S, Hang ZZ, Garcia J, Garcia Z, Marchorro P, Beteta E, Giron A, Hamers R, Inzaule S, Frenkel LM, Chung MH, de Oliveira T, Pillay D, Naidoo K, Kharsany A, Kugathasan R, Cutino T, Hunt G, Avila Rios S, Doherty M, Jordan MR, Bertagnolio S. Gupta RK, et al. Lancet Infect Dis. 2018 Mar;18(3):346-355. doi: 10.1016/S1473-3099(17)30702-8. Epub 2017 Dec 5. Lancet Infect Dis. 2018. PMID: 29198909 Free PMC article.